| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $169.5M | +116.1% |
| SG&A Expense | $39.8M | +57.6% |
| Operating Income | -$232.3M | -124.0% |
| Interest Expense | $2K | -71.4% |
| Net Income | -$223.5M | -123.3% |
| EPS (Basic) | -$3.44 | -78.2% |
| EPS (Diluted) | -$3.44 | -78.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $834.7M | +1109.9% |
| Short-term Investments | $96.7M | -45.4% |
| Current Assets | $942.6M | +267.7% |
| Total Assets | $1.01B | +210.2% |
| Current Liabilities | $40.5M | +41.1% |
| Total Liabilities | $52.6M | +30.4% |
| Stockholders' Equity | $953.6M | +235.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$170.6M | -40.5% |
| Capital Expenditures | $5.8M | -10.8% |
| Investing Cash Flow | $74.6M | +135.1% |
| Financing Cash Flow | $861.5M | +4741.2% |
| Free Cash Flow | -$176.4M | -37.9% |